ֱ

Brain Aging Biomarkers; Midlife Anxiety and Dementia Risk; Who Chose Assisted Dying?

— News and commentary from the world of neurology and neuroscience

MedpageToday
Neuro Break over a computer rendering of neurons.

Researchers identified 13 proteins that predicted how quickly or slowly a . (Nature Aging)

Midlife anxiety was common decades before , the Norwegian HUNT study showed. (Alzheimer's & Dementia)

Investigational tavapadon in a flexible dosing phase III trial of Parkinson's disease, showing improvements from baseline in symptoms and quality of life scores at week 26, AbbVie announced.

The p38MAP kinase alpha enzyme inhibitor neflamapimod missed its primary and secondary endpoints in a phase II study of CervoMed said.

Neurodegeneration in the cortical sulcus was a feature of and was associated with repetitive head impacts, autopsy data showed. (Acta Neuropathologica)

People with or cancer were more likely than others to choose assisted dying regardless of where they lived, an analysis found. (JAMA Internal Medicine)

Dementia risk was in Scotland despite modifiable dementia risk factors being lower or no different than population controls. (JAMA Network Open)

Diverse cell types in the brain parenchyma contribute to disease, a review showed. (Nature Reviews Immunology)

The Washington Post highlighted award-winning images with Alzheimer's.

CNN looked at against Parkinson's.

  • Judy George covers neurology and neuroscience news for ֱ, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.